Key facts
- It has raised $7.0M; the latest was Early Stage VC ($7.0M) in May 2025.
- Notable investors include Kidron, Wasatch Health.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for PorTal (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for PorTal (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PorTal (Therapeutic Devices)
Developer of a vascular access device designed for oncology patients undergoing chemotherapy. The company's device features a chemotherapy port to simplify vascular access, enhance usability, reduce procedural complexity, and broaden accessibility in additional care settings, enabling healthcare providers to reduce treatment delays, minimize procedural risks, lower healthcare costs, and improve cancer care delivery and patient experience.
- Sector
- Healthcare
- HQ
- Israel
- Employees
- 2
- Ownership
- Privately Held (backing)
PorTal (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PorTal (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PorTal (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.